- Home
- ASRT vs CODA Comparison
ASRT vs CODA Comparison
Compare ASRT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | CODA |
|---|---|---|
| Founded | 1995 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 91.5M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASRT | CODA |
|---|---|---|
| Price | $0.78 | $8.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 754.0K | 43.1K |
| Earning Date | 11-10-2025 | 09-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.09 |
| EPS | N/A | ★ 0.30 |
| Revenue | ★ $137,354,000.00 | $24,347,217.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | $4.10 | $20.84 |
| P/E Ratio | ★ N/A | $29.15 |
| Revenue Growth | 9.22 | ★ 29.34 |
| 52 Week Low | $0.51 | $5.76 |
| 52 Week High | $1.04 | $10.54 |
Technical Indicators
Market Signals| Indicator | ASRT | CODA |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 51.76 |
| Support Level | $0.65 | $8.25 |
| Resistance Level | $0.79 | $8.89 |
| Average True Range (ATR) | 0.04 | 0.41 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 72.73 | 91.04 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.